TMBR Timber Pharmaceuticals Inc.

2.7
-0.18  -6%
Previous Close 2.88
Open 2.82
Price To Book
Market Cap 49,351,191
Shares 18,278,219
Volume 1,126,725
Short Ratio 1.33
Av. Daily Volume 327,649
Stock charts supplied by TradingView

NewsSee all news

  1. Timber Pharmaceuticals Announces Merger Closing

    WOODCLIFF LAKE, N.J., May 18, 2020 /PRNewswire/ -- Timber Pharmaceuticals, Inc., (NYSE:TMBR), formerly known as BioPharmX Corporation ("Timber" or the "Company"), a biopharmaceutical company focused on

  2. Timber Pharmaceuticals Announces Investor Conference Call

    Call to be held on Tuesday, May 26th at 11:00am EDT WOODCLIFF LAKE, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE:TMBR), a

Drug Information

Drug catalyst information is displayed when you hover over / tap on the stage bar graph.

Phase 2b data June 25, 2019 met endpoints.
BPX-04
Rosacea

Latest News

  1. Timber Pharmaceuticals Announces Merger Closing

    WOODCLIFF LAKE, N.J., May 18, 2020 /PRNewswire/ -- Timber Pharmaceuticals, Inc., (NYSE:TMBR), formerly known as BioPharmX Corporation ("Timber" or the "Company"), a biopharmaceutical company focused on

  2. Timber Pharmaceuticals Announces Investor Conference Call

    Call to be held on Tuesday, May 26th at 11:00am EDT WOODCLIFF LAKE, N.J., May 19, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Timber Pharmaceuticals, Inc. ("Timber" or the "Company") (NYSE:TMBR), a